The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
Issued on behalf of Conexeu Sciences Inc. A newly listed regenerative-tissue company has put its lead breast-reconstruction matrix on the bench at one of the world's largest bioprinting institutes. For investors tracking the space, the partner it chose may matter more than anything it has...
Issued on behalf of Conexeu Sciences Inc. A newly listed regenerative-tissue company has put its lead breast-reconstruction matrix on the bench at one of the world's largest bioprinting institutes. For investors tracking the space, the partner it chose may matter more than anything it has...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.